Do selected drugs increase the risk of lupus? A matched case-control study

British Journal of Clinical Pharmacology

Volumn 70, Issue 4, 2010, Pages 588-596

  Schoonen, W Marieke ^a   Thomas, Sara L ^b   Somers, Emily C ^b,c   Smeeth, Liam ^b   Kim, Joseph ^a   Evans, Stephen ^b   Hall, Andrew J ^b  

^a AMGEN LTD   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

carbamazepine; case control study; drug induced lupus; epidemiology; hydralazine; minocycline

Indexed keywords

ACEBUTOLOL; ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARBAMAZEPINE; CHLORPROMAZINE; DIAZEPAM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXYCYCLINE; HYDRALAZINE; HYDRAZIDE DERIVATIVE; ISONIAZID; METHYLDOPA; MINOCYCLINE; NEUROLEPTIC AGENT; PROCAINAMIDE; PROPYLTHIOURACIL; QUINIDINE; SALBUTAMOL; TETRACYCLINE; VASODILATOR AGENT;

ACNE; ANGINA PECTORIS; ARTICLE; BACTERIAL INFECTION; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; DRUG INDUCED DISEASE; DRUG SAFETY; EPILEPSY; HEART ARRHYTHMIA; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPERTHYROIDISM; LUPUS LIKE SYNDROME; MAJOR CLINICAL STUDY; MALARIA; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT; SCHIZOPHRENIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TUBERCULOSIS; UNITED KINGDOM;

ADULT; ANTI-ARRHYTHMIA AGENTS; ANTI-BACTERIAL AGENTS; ANTICONVULSANTS; ANTIHYPERTENSIVE AGENTS; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEDICAL RECORDS; MIDDLE AGED; PRESCRIPTION DRUGS; RISK; SEX FACTORS; VASODILATOR AGENTS;

EID: 77956604471     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2010.03733.x     Document Type: Article

References (21)

1. Yung RL, Richardson BC. Drug-induced lupus. Rheum Dis Clin North Am 1994 20:61 86.
2. Borchers AT, Keen CL, Gershwin ME. Drug-induced lupus. Ann N Y Acad Sci 2007 1108:166 182.
3. Rubin RL. Drug-induced lupus. Toxicology 2005 209:135 147.
4. Rubin RL. Etiology and mechanisms of drug-induced lupus. Curr Opin Rheumatol 1999 11:357 363.
5. Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol 2007 3:521 527.
6. Lawrenson R, Williams T, Farmer R. Clinical information for research; the use of general practice databases. J Public Health Med 1999 21:299 304.
7. Key Health Statistics from General Practice 1996. Office for National Statistics, editor. London:The Stationery Office, 1998.
8. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997 350:1097 1099.
9. Hollowell J. The General Practice Research Database: quality of morbidity data. Popul Trends 1997 87:36 40.
10. Somers EC, Thomas SL, Smeeth L, Schoonen WM, Hall AJ. Incidence of systemic lupus erythematosus in the United Kingdom, 1990-1999. Arthritis Rheum 2007 57:612 618.
11. Lewis JD, Bilker WB, Weinstein RB, Strom BL. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2005 14:443 451.
12. Sturkenboom MC, Meier CR, Jick H, Stricker BH. Minocycline and lupus-like syndrome in acne patients. Arch Intern Med 1999 159:493 497.
13. Margolis DJ, Hoffstad O, Bilker W. Association or lack of association between tetracycline class antibiotics used for acne vulgaris and lupus erythematosus. Br J Dermatol 2007 157:540 546.
14. Rubin RL. Chapter 8: Environmentally induced systemic lupus erythematosus. In:Rheumatic Diseases and the Environment, eds Kaufman L, Varga J. London:Arnold Publishers, 1999 83 100.
15. Rubin R. Chapter 42. Drug-induced lupus. In:Dubois' Lupus Erythematosus, 6th edn, eds Wallace D, Hahn B. Philadelphia, PA:Lippincott Williams & Wilkins, 2002 885 916.
16. Schlienger RG, Bircher AJ, Meier CR. Minocycline-induced lupus. A systematic review. Dermatology 2000 200:223 231.
17. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982 25:1271 1277.
18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997 40:1725.
19. Collet J-P, Boivin J-F. Bias and confounding in pharmacoepidemiology. In:Pharmacoepidemiology, 3rd edn, ed. Strom BL. Chichester, UK:John Wiley & Sons, 2000 764 784.
20. Ramos-Casals M, Brito-Zeron P, Soto MJ, Cuadrado MJ, Khamashta MA. Autoimmune diseases induced by TNF-targeted therapies. Best Pract Res Clin Rheumatol 2008 22:847 861.
21. Askling J, Fored CM, Geborek P, Jacobsson LT, van Vollenhoven R, Feltelius N, Lindblad S, Klareskog L. Swedish registers to examine drug safety and clinical issues in RA. Ann Rheum Dis 2006 65:707 712.